Avantec Vascular is dedicated to advancing vascular therapies through innovation. Avantec is a rapidly growing, privately held corporation that develops, manufactures and markets innovative products for the treatment of vascular disease. The company’s focus is developing products for the treatment of Coronary Artery Disease (CAD). Avantec’s initial products include the Duraflex™ Coronary Stent System and the Apollo™ Coronary Dilatation Catheter. In addition, Avantec is developing a number of advanced technology platforms. Within interventional cardiology, a primary area of focus is the development of the company’s proprietary drug eluting stent system. Avantec Vascular Corporation’s products are not available
for sale in the United States.